Valuation: Boston Scientific Corporation

Market Cap 65.3B 58.61B 54.12B 49.07B 91.72B 6,203B 92.85B 649B 258B 3,251B 245B 240B 10,310B P/E 2026 *
17.1x
P/E 2027 * 17.9x
Enterprise Value 71.71B 64.36B 59.43B 53.89B 101B 6,812B 102B 713B 283B 3,570B 269B 263B 11,322B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.2x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day+0.55%
1 week-1.14%
Current month+3.23%
1 month+2.60%
3 months-0.99%
6 months-24.84%
Current year-52.74%
1 week 44.62
Extreme 44.62
46.16
1 month 41.38
Extreme 41.385
46.16
Current year 41.38
Extreme 41.385
100.9
1 year 41.38
Extreme 41.385
105.65
3 years 41.38
Extreme 41.385
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Buy

Director

2,040 0.0001%
11/8/26 Other

Controller/Auditor

2,930 0.0002%
10/8/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-1.14%-56.01%-9.01% 65.3B
+1.19%+0.82%+22.92%+60.64% 256B
-0.42%+3.46%+4.97%+23.48% 163B
-1.27%+1.80%-19.11%+72.17% 155B
-0.10%+0.31%-14.37%-8.59% 51.93B
+0.29%+2.87%+12.37%+47.17% 52.35B
-1.48%-1.63%+6.01%+65.40% 50.75B
+0.87%+2.59%+21.08%+72.71% 50.04B
+2.76%+5.81%+33.21%+91.43% 46.03B
+3.11%+4.31%+178.50%+155.88% 42.2B
Average +0.55%+1.99%+18.96%+57.13% 93.26B
Weighted average by Cap. +0.33%+1.80%+11.15%+53.30%

Financials

2026 *2027 *
Net sales 21.13B 18.96B 17.51B 15.88B 29.67B 2,007B 30.04B 210B 83.36B 1,052B 79.3B 77.6B 3,335B 22.14B 19.87B 18.34B 16.64B 31.09B 2,103B 31.47B 220B 87.35B 1,102B 83.09B 81.31B 3,495B
Net income 3.75B 3.37B 3.11B 2.82B 5.27B 356B 5.34B 37.29B 14.81B 187B 14.09B 13.79B 593B 3.68B 3.3B 3.05B 2.76B 5.16B 349B 5.23B 36.52B 14.5B 183B 13.8B 13.5B 580B
Net Debt 6.41B 5.75B 5.31B 4.82B 9B 609B 9.11B 63.69B 25.29B 319B 24.06B 23.55B 1,012B 5.49B 4.93B 4.55B 4.13B 7.72B 522B 7.81B 54.59B 21.68B 274B 20.63B 20.18B 868B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
27/10/26 USD 45.06 -1.14% 15,139,721
26/10/26 USD 45.58 -0.24% 11,928,715
23/10/26 USD 45.69 -0.70% 8,772,772
22/10/26 USD 46.01 +3.37% 16,395,574
21/10/26 USD 44.51 -2.35% 15,193,231
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
45.06USD
Average target price
57.82USD
Spread / Average Target
+28.32%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation